FHC Group
Rita Belo Jorge is currently working as a Medical Information Specialist & Pharmacovigilance Officer at FHC Group, as well as a Scientific communication specialist at Novartis and Sandoz, representing Phagecon. Prior to these roles, Rita served as a Technical Director at Therafuture Medical, Lda, where Rita held the position of Regulatory Affairs & Quality Manager. Rita also has experience in the pharmaceutical industry through their role as a Medical Specialist Trainee at Merck Portugal, where Rita focused on Medical Specialty Trainee in various areas. Rita has a solid educational background, having pursued degrees in Pharmacy, Regulatory Affairs & Technical Direction, and Química.
FHC Group
The FHC Group is one of the most relevant business groups in the pharmaceutical area in Portugal, present in all sectors of Pharma value chain of medicines, with recognized specialization and recognition in the industrial area, distribution in the retail pharmacy and hospital market, export and internationalization, R&D as well as in the pharmaceutical consultancy area. The FHC group begins its foundation with the creation of the company “FHC | Farmacêutica” in 1998, dedicated to the international market. After consolidates its position in the pharmaceutical industrial sector with the acquisition and dynamization of Basi laboratories in 2003. The FHC Group is a Portuguese multinational with origin and capital exclusively private and present in 4 continents.